p16INK4 expression in precursor lesions of squamous cell cervical cancer related to the presence of HPV-DNA

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 7, 2008, Pages 583-588

  Godoy, A E G ^a   Mandelli, J ^a   Oliveira, F H ^a   Calegari, S ^a   Moura, L B ^a   Serafini, E P ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Cervical cancer; Human papillomavirus; Immunohistochemistry; p16INK

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; CASE CONTROL STUDY; HOSPITALIZATION; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 52949124844     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000700006     Document Type: Article

References (28)

1. Kjellberg L, Wadell G, Bergman F, Isaksson M, Angstrom T, Dillner J. Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. Am J Obstet Gynecol 2000; 183: 1238-1242.
2. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002; 156: 158-164.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
5. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999; 42: 206-220.
6. Falls RK. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol 1999; 181: 278-282.
7. Ledger WJ, Jeremias J, Witkin SS. Testing for high-risk human papillomavirus types will become a standard of clinical care. Am J Obstet Gynecol 2000; 182: 860-865.
8. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63.
9. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1995; 87: 1345-1347.
10. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In: Kurman RJ (Editor), Blaustein's pathology of female genital tract. 4th edn. New York, Springer-Verlag; 1994. p 229-278.
11. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complementary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884-891.
12. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677.
13. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-1748.
14. Huschtscha LI, Reddel RR. p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis 1999; 20: 921-926.
15. Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao MJ, Tommasino M. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J Virol 2001; 75: 4705-4712.
16. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16: 665-673.
17. Wieland U, Pfister H. Infecção por papilomavírus em patologia humana: epidemiologia, patogenese e papel oncogênico. In: Gross GE, Barrasso R (Editors), Papilomavírus humano - atlas clínico de HPV. 1st edn. Porto Alegre: ArtMed; 1999.
18. Kubo A, Nakagawa K, Varma RK, Conrad NK, Cheng JQ, Lee WC, et al. The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4. Clin Cancer Res 1999; 5: 4279-4286.
19. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990; 75: 131-133.
20. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-361.
21. Nonnenmacher B, Breitenbach V, Villa LL, Prolla JC, Bozzetti MC. Genital human papillomavirus infection identification by molecular biology among asymptomatic women. Rev Saúde Pública 2002; 36: 95-100.
22. Cavalcanti SM, Zardo LG, Passos MR, Oliveira LH. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 2000; 40: 80-87.
23. Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjose S, Ascunce N, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 1996; 23: 504-510.
24. Kulmala SM, Syrjanen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004; 42: 2470-2475.
25. Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CY. Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000; 183: 39-45.
26. Branca M, Ciotti M, Santini D, di Bonito L, Giorgi C, Benedetto A, et al. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 2004; 23: 354-365.
27. Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 2005; 29: 674-679.
28. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284.